5-lipoxygenase-activating protein (FLAP) inhibitors
US7405302B2 · kind B2 · utility
94Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2006 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Oct 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.